Sarnath Chattaraj,Kiem H. Dang,Hsi Chung Fusselman,Poonam S. Gulati,Lance P. Hoffman,Guangping Zhang
申请号：
US16693050
公开号：
US20200138852A1
申请日:
2019.11.22
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated with the treatment of the diabetic patient where the treatment requires subcutaneous implantation of a foreign body, such as a cannula or catheter. In certain embodiments of the invention, a response-inhibiting agent is administered to a patient at the site of cannula/catheter insertion, thereby facilitating delivery of insulin to the diabetic patient and mitigating site-loss and/or occlusion over a period of time.
